Cooper Companies (NASDAQ:COO) Price Target Lowered to $86.00 at Needham & Company LLC

Cooper Companies (NASDAQ:COO) had its price target lowered by equities research analysts at Needham & Company LLC from $101.00 to $86.00 in a note issued to investors on Friday, MarketBeat.com reports. The brokerage presently has a “buy” rating on the medical device company’s stock. Needham & Company LLC’s price objective suggests a potential upside of 38.66% from the stock’s previous close.

Several other equities research analysts have also recently weighed in on the company. Barclays increased their target price on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, March 6th. Mizuho set a $85.00 price objective on Cooper Companies and gave the company an “outperform” rating in a research note on Thursday. Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the stock an “overweight” rating in a report on Monday. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 price target on shares of Cooper Companies in a report on Friday. Finally, Rothschild & Co Redburn lowered shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a report on Wednesday, March 4th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $84.79.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $62.02 on Friday. Cooper Companies has a 52-week low of $58.89 and a 52-week high of $89.83. The stock has a market capitalization of $12.10 billion, a price-to-earnings ratio of 30.70, a price-to-earnings-growth ratio of 1.56 and a beta of 0.87. The company has a fifty day moving average of $65.17 and a 200-day moving average of $74.57. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the company earned $0.96 EPS. The firm’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts expect that Cooper Companies will post 4.62 EPS for the current year.

Institutional Trading of Cooper Companies

Several institutional investors and hedge funds have recently bought and sold shares of COO. Root Financial Partners LLC grew its holdings in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the period. SJS Investment Consulting Inc. lifted its stake in shares of Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares during the period. Bell Investment Advisors Inc boosted its position in shares of Cooper Companies by 106.3% during the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in Cooper Companies in the second quarter worth $36,000. Finally, True Wealth Design LLC grew its stake in Cooper Companies by 484.8% in the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.